Zobrazeno 1 - 10
of 140
pro vyhledávání: '"Esa, Läärä"'
Autor:
Mayu Hosio, Elina Urpilainen, Ari Hautakoski, Martti Arffman, Reijo Sund, Anne Ahtikoski, Ulla Puistola, Arja Jukkola, Esa Läärä, Peeter Karihtala
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract We investigated the association of prediagnostic use of menopausal hormone therapy (MHT) with breast cancer survival among women with type 2 diabetes (T2D). The study cohort was identified from a Finnish nationwide diabetes database, and con
Externí odkaz:
https://doaj.org/article/6076ca2cd9bc46fdb1d58fbeeec9c7a0
Autor:
Aleksi Laajala, Paulus Tokola, Timo J. Autio, Timo Koskenkorva, Mikko Tastula, Pasi Ohtonen, Esa Läärä, Olli-Pekka Alho
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/53a787bf424540f6a67870866240b99e
Autor:
Aleksi Laajala, Paulus Tokola, Timo J. Autio, Timo Koskenkorva, Mikko Tastula, Pasi Ohtonen, Esa Läärä, Olli-Pekka Alho
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-13 (2021)
Abstract Background Tonsillar surgery has been used for decades to treat recurrent and chronic tonsillitis in adults. Recurrent and chronic tonsillitis result in disturbing symptoms, treatment costs, sick leave, and impaired quality of life (QoL). Th
Externí odkaz:
https://doaj.org/article/3572a7d370c94aa68ee210819d296ffa
Autor:
Sami Erkinantti, Ari Hautakoski, Reijo Sund, Martti Arffman, Elina Urpilainen, Ulla Puistola, Arja Jukkola, Karihtala Peeter, Esa Läärä
Publikováno v:
Cancer Control, Vol 29 (2022)
Background Use of metformin and statins have been associated with improved prognosis of colon cancer (CC) in patients with type 2 diabetes (T2D). We examined the survival from CC in relation to the use of metformin, other oral antidiabetic medication
Externí odkaz:
https://doaj.org/article/0903b6a7cbb5434bab9512eba18934ed
Autor:
Mayu Hosio, Elina Urpilainen, Ari Hautakoski, Mikko Marttila, Martti Arffman, Reijo Sund, Anne Ahtikoski, Ulla Puistola, Esa Läärä, Peeter Karihtala, Arja Jukkola
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract We investigated the survival of female patients with pre-existing type 2 diabetes (T2D) diagnosed with invasive ductal carcinoma (IDC) and invasive lobular carcinoma (ILC) of breast, in relation to the use of metformin, other antidiabetic me
Externí odkaz:
https://doaj.org/article/0b4d4abd0eaf4665929c979a0ba8d789
Autor:
Sami Erkinantti, Ari Hautakoski, Reijo Sund, Martti Arffman, Elina Urpilainen, Ulla Puistola, Esa Läärä, Arja Jukkola, Peeter Karihtala
Publikováno v:
Biomolecules, Vol 12, Iss 9, p 1301 (2022)
Metformin and statin use have been associated with an improved prognosis for colorectal cancer in persons with type 2 diabetes (T2D). Data regarding rectal cancer (RC) have been inconclusive; therefore, we investigated the issue with high-quality dat
Externí odkaz:
https://doaj.org/article/90014f77530946539e4398ab0fdf160e
Autor:
Jaana Vuosku, Riina Muilu-Mäkelä, Komlan Avia, Marko Suokas, Johanna Kestilä, Esa Läärä, Hely Häggman, Outi Savolainen, Tytti Sarjala
Publikováno v:
Frontiers in Plant Science, Vol 10 (2019)
Unlike in flowering plants, the detailed roles of the enzymes in the polyamine (PA) pathway in conifers are poorly known. We explored the sequence conservation of the PA biosynthetic genes and diamine oxidase (DAO) in conifers and flowering plants to
Externí odkaz:
https://doaj.org/article/4f501197d4c7456ca5c4596ead1618ce
Autor:
Elina Urpilainen, Mikko Marttila, Ari Hautakoski, Martti Arffman, Reijo Sund, Pirjo Ilanne-Parikka, Reetta Arima, Jenni Kangaskokko, Ulla Puistola, Marianne Hinkula, Esa Läärä
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Ovarian cancer is one of the most lethal cancers and women with type 2 diabetes (T2D) have even poorer survival from it. We assessed the prognosis of ovarian cancer in women with type 2 diabetes treated with metformin, other forms
Externí odkaz:
https://doaj.org/article/89b019bf7d78410890312a2f4eddbf19
Publikováno v:
Journal of Education for Teaching. 49:180-193
Autor:
Peeter Karihtala, Martti Arffman, Ulla Puistola, Mikko Marttila, Esa Läärä, Arja Jukkola, Elina Urpilainen, Sami Erkinantti, Ari Hautakoski, Reijo Sund
Publikováno v:
Clinical Colorectal Cancer. 20:e113-e119
Background Metformin and statins may have anticancer effects, with plausible cellular mechanisms. However, the association of these agents with the risk of colorectal cancer is unclear. Patients and Methods This was a retrospective cohort study on a